Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Lotus Pharmaceutical Industries.

    Client Virtual Booth

    LOTUS PHARMACEUTICAL INDUSTRIES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Lotus Pharmaceutical Industries
    Egypt Flag
    Country
    Country
    Egypt
    Address
    Address
    20,Thawra St., Dokki, Giza
    Telephone
    Telephone
    + 202 33350205
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lotus-pharma.net/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea

    Details:

    The partnership aims to distribute and commercialize Vazkepa (icosapent ethyl), approved and commercialized in a number of global markets, including the U.S. and European markets, across 10 countries, including nine in Southeast Asia and South Korea.


    Lead Product(s): Icosapent Ethyl

    Therapeutic Area: Cardiology/Vascular Diseases Product Name: Vazkepa

    Highest Development Status: ApprovedProduct Type: Small molecule

    Recipient: Amarin

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership July 31, 2023

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Lotus Acquires Cialis® (Tadalafil) in Taiwan From Lilly

    Details:

    Cialis® (tadalafil), is indicated for the treatment of erectile dysfunction and benign prostatic hyperplasia, and Cialis® is positioned as the top 2 brand product for erectile dysfunction treatment with high brand loyalty.


    Lead Product(s): Tadalafil

    Therapeutic Area: Psychiatry/Psychology Product Name: Cialis

    Highest Development Status: ApprovedProduct Type: Small molecule

    Recipient: Eli Lilly

    Deal Size: $57.5 million Upfront Cash: Undisclosed

    Deal Type: Acquisition March 22, 2022

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search